Matches in Wikidata for { <http://www.wikidata.org/entity/Q66063044> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q66063044 description "clinical trial" @default.
- Q66063044 description "ensayu clínicu" @default.
- Q66063044 description "klinisch onderzoek" @default.
- Q66063044 description "клінічне випробування" @default.
- Q66063044 name "Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer" @default.
- Q66063044 name "Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer" @default.
- Q66063044 type Item @default.
- Q66063044 label "Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer" @default.
- Q66063044 label "Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer" @default.
- Q66063044 prefLabel "Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer" @default.
- Q66063044 prefLabel "Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer" @default.
- Q66063044 P1050 Q66063044-57D57925-0C76-4553-89DA-B757B66559B6 @default.
- Q66063044 P1132 Q66063044-4F6765E5-BE79-416D-83E0-4762049E85CB @default.
- Q66063044 P1476 Q66063044-79559253-B9CC-4A6A-97B5-D331018E2CFD @default.
- Q66063044 P2899 Q66063044-FA7CE00B-7732-4DCE-BCEF-7AE0BD76ED4B @default.
- Q66063044 P3098 Q66063044-01EC34BD-90C0-4159-AA62-0310615550FE @default.
- Q66063044 P31 Q66063044-B97667A4-BE8F-498A-9E2D-E0E915311A7A @default.
- Q66063044 P4135 Q66063044-DE7312CF-27D5-47C2-9AAD-34A4DF0206C4 @default.
- Q66063044 P580 Q66063044-ABB9A7C2-72D9-4EB0-8692-E49EB7D45D79 @default.
- Q66063044 P582 Q66063044-40813A7D-54B4-4593-8C34-0E413553CB06 @default.
- Q66063044 P6099 Q66063044-3D3EFC11-D616-43D3-91CE-562CAAB98777 @default.
- Q66063044 P8363 Q66063044-43ADC6D8-28F5-470A-9EB0-A5C6535ACDE9 @default.
- Q66063044 P1050 Q1435822 @default.
- Q66063044 P1132 "+130" @default.
- Q66063044 P1476 "Study on the Efficacy and Safety of 4.5mg Pegylated Recombinant Human Granulocyte Colony Stimulating Factor Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer" @default.
- Q66063044 P2899 "+18" @default.
- Q66063044 P3098 "NCT04009941" @default.
- Q66063044 P31 Q30612 @default.
- Q66063044 P4135 "+65" @default.
- Q66063044 P580 "2019-07-01T00:00:00Z" @default.
- Q66063044 P582 "2021-05-30T00:00:00Z" @default.
- Q66063044 P6099 Q42825046 @default.
- Q66063044 P8363 Q78089383 @default.